ArticleCancer management and research2020

Therapeutic Effect of Trastuzumab in Neoadjuvant-Treated HER2-Positive Breast Cancer with Low Infiltrating Level of Tumor-Infiltrating Lymphocytes.

Shiwei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.